{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.2:c.158C>T",
          "cDNA Change": {
            "transcript": "NM_000345.2",
            "ref": "C",
            "alt": "T",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T mutation"
        },
        {
          "HGVS": "NM_000345.2:c.136G>A",
          "cDNA Change": {
            "transcript": "NM_000345.2",
            "ref": "G",
            "alt": "A",
            "position": "136"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "46"
          },
          "Description in input context": "E46K mutation"
        },
        {
          "HGVS": "NM_000345.2:c.90C>T",
          "cDNA Change": {
            "transcript": "NM_000345.2",
            "ref": "C",
            "alt": "T",
            "position": "90"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P mutation"
        },
        {
          "HGVS": "NM_000345.2:c.625G>A",
          "cDNA Change": {
            "transcript": "NM_000345.2",
            "ref": "G",
            "alt": "A",
            "position": "625"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "A",
            "position": "209"
          },
          "Description in input context": "G209A mutation"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005164"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y",
        "Description": "Protein expression levels were analyzed in SH-SY5Y cells overexpressing mutant SNCA variants."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.2:c.158C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased α-synuclein aggregation and reduced cell viability in A53T-expressing cells."
        },
        {
          "Variant": "NM_000345.2:c.136G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Enhanced oligomerization and neurotoxicity in E46K-expressing cells."
        },
        {
          "Variant": "NM_000345.2:c.90C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased fibrillization and mitochondrial dysfunction in A30P-expressing cells."
        },
        {
          "Variant": "NM_000345.2:c.625G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Reduced α-synuclein solubility and increased oxidative stress in G209A-expressing cells."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments were repeated with three independent biological replicates."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type SNCA-expressing cells were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector-transfected cells were used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "2"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA followed by Tukey's post-hoc test."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression within 10% of wild-type levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression exceeding 20% of wild-type levels or aggregation observed.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunohistochemistry",
      "Material used": {
        "Material Source": "Animal Model",
        "Material Name": "Transgenic mice",
        "Description": "Brain tissues from transgenic mice expressing mutant SNCA variants were analyzed for α-synuclein pathology."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000345.2:c.158C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Presence of Lewy body-like inclusions in A53T mice brains."
        },
        {
          "Variant": "NM_000345.2:c.136G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased α-synuclein pathology in E46K mice brains."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Analysis performed on 6 mice per group."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each brain section was analyzed in duplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type mice brains were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative控制": "Yes",
        "Description": "Non-transgenic mice brains were used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Chi-square test for categorical data."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "No detectable α-synuclein pathology.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Presence of Lewy body-like inclusions or abnormal staining patterns.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}